scholarly journals Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target

2013 ◽  
Vol 333 (1) ◽  
pp. 9-17 ◽  
Author(s):  
Yang Yang ◽  
Saradhi Mallampati ◽  
Baohua Sun ◽  
Jing Zhang ◽  
Sang-Bae Kim ◽  
...  
2019 ◽  
Author(s):  
Sana Usmani ◽  
Urmila Sivagnanalingam ◽  
Olena Tkachenko ◽  
Leti Nunez ◽  
Jessica Shand ◽  
...  

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 1027-1027
Author(s):  
Zhongbo Hu ◽  
Xiaomiao Li ◽  
David Ostrov ◽  
William Slayton

Abstract Abstract 1027 Integrin VLA-5 (α5β1, CD49e/CD29) plays an important role in hematopoietic cells functioning as well as in promoting tumor angiogenesis and tumor metastasis. Molecules targeting VLA-5 can be rapidly developed into anti-inflammatory and anti-tumor pharmaceuticals. VLA-5 is highly expressed on Ph+ leukemia cells and VLA-5 inhibitory antibodies can significantly inhibit the adhesion of Ph+ leukemia cells to human fibronectin. We generated an atomic homology model of VLA-5 based on the crystal structure of the extracellular segment of integrin αVβ3 in complex with a cyclic peptide presenting the Arg-Gly-Asp sequence and utilized this structure-based approach to identify VLA-5 binding drug-like small molecules. We selected the Arg-Gly-Asp binding residues and the epitopes of VLA-5 antibody as the target for small molecule binding using SPHERE_SELECT in DOCK6. The grid-based scoring system was used for scoring with the non-bonded force field energy function. The 100 highest scoring small molecules were assayed in an in vitro adhesion assay using leukemia cell lines and solid phase assay. This approach identified several leading small-molecule compounds, V10, V20, V37 and L4. Their IC50 are respectively 22.5μM, 23.7μM, 32.0μM and 28.9μM. These compounds can inhibit the adhesion of VLA-5 expressing Philadelphia chromosome positive leukemia to both human fibronectin and bone marrow stromal cells. Compounds V10 and V20 also significantly inhibited the growth of Ph+ leukemia cells. These compounds can enhance the effect of imatinib and dasatinib to kill Ph+ leukemia cells when cultured contacting with bone marrow stromal cells. We are currently testing the synergistic effect of these compounds with tyrosine kinase inhibitors to treat the Ph+ acute lymphoblastic leukemia in NOD/SCID animal model. Disclosures: No relevant conflicts of interest to declare.


2012 ◽  
Vol 36 (3) ◽  
pp. 299-306 ◽  
Author(s):  
Yordanos Tesfai ◽  
Jette Ford ◽  
Kim W. Carter ◽  
Martin J. Firth ◽  
Rebecca A. O’Leary ◽  
...  

Blood ◽  
2016 ◽  
Vol 128 (3) ◽  
pp. 453-456 ◽  
Author(s):  
Suzanne M. Johnson ◽  
Clare Dempsey ◽  
Amy Chadwick ◽  
Stephanie Harrison ◽  
Jizhong Liu ◽  
...  

Blood ◽  
2011 ◽  
Vol 118 (25) ◽  
pp. 6506-6514 ◽  
Author(s):  
Armel Hervé Nwabo Kamdje ◽  
Mauro Krampera

Abstract Notch signaling pathway regulates many different events of embryonic and adult development; among them, Notch plays an essential role in the onset of hematopoietic stem cells and influences multiple maturation steps of developing lymphoid and myeloid cells. Deregulation of Notch signaling determines several human disorders, including cancer. In the last decade it became evident that Notch signaling plays pivotal roles in the onset and development of T- and B-cell acute lymphoblastic leukemia by regulating the intracellular molecular pathways involved in leukemia cell survival and proliferation. On the other hand, bone marrow stromal cells are equally necessary for leukemia cell survival by preventing blast cell apoptosis and favoring their reciprocal interactions and cross-talk with bone marrow microenvironment. Quite surprisingly, the link between Notch signaling pathway and bone marrow stromal cells in acute lymphoblastic leukemia has been pointed out only recently. In fact, bone marrow stromal cells express Notch receptors and ligands, through which they can interact with and influence normal and leukemia T- and B-cell survival. Here, the data concerning the development of T- and B-cell acute lymphoblastic leukemia has been critically reviewed in light of the most recent findings on Notch signaling in stromal microenvironment.


PLoS ONE ◽  
2012 ◽  
Vol 7 (5) ◽  
pp. e37203 ◽  
Author(s):  
Patricia Macanas-Pirard ◽  
Andrea Leisewitz ◽  
Richard Broekhuizen ◽  
Kelly Cautivo ◽  
Francisco M. Barriga ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document